Brief: Prothena Provides Update On PRX012 And Announces Results From The Phase 1 Ascent Clinical Program
27/08/2025 21:30
Aug 27 (Reuters) - Prothena Corporation PLC PRTA.O: PROTHENA PROVIDES UPDATE ON PRX012 AND ANNOUNCES RESULTS FROM THE PHASE 1 ASCENT CLINICAL PROGRAM Source text: ID:nBw9VCjra Further company coverage: PRTA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prothena
See all newsProthena Corporation PLC reports results for the quarter ended June 30 - Earnings Summary
Biotech firm Prothena's Q2 net loss narrows on lower expenses
Brief: Prothena Q2 Net Income USD -18.583 Million
Prothena Corporation PLC expected to post a loss of 39 cents a share - Earnings Preview
Prothena posts Q1 revenue surge fueled by $50 million Novo Nordisk milestone payment